Zhaoyi Wang Selected Research

Estrogens (Estrogen)

1/2020	ER-α36 mediates gastric cancer cell invasion.
6/2018	Estrogen receptor-α36-mediated rapid estrogen signaling regulates 78 kDa glucose-regulated protein expression in gastric carcinoma cells.
1/2017	Effects of 17β-estradiol and tamoxifen on gastric cancer cell proliferation and apoptosis and ER-α36 expression.
12/2014	Biphasic ER-α36-mediated estrogen signaling regulates growth of gastric cancer cells.
1/2014	Estrogen receptor-α36 is involved in pterostilbene-induced apoptosis and anti-proliferation in in vitro and in vivo breast cancer.
8/2013	ER-α36-mediated gastric cancer cell proliferation via the c-Src pathway.
11/2011	Expression and function of a novel variant of estrogen receptor-α36 in murine airways.
5/2010	Caveolin-1 gene silencing promotes the activation of PI3K/AKT dependent on Eralpha36 and the transformation of MCF10ACE.
11/2008	Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues.
6/2006	A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhaoyi Wang Research Topics

Disease

22	Neoplasms (Cancer) 11/2023 - 06/2006
10	Breast Neoplasms (Breast Cancer) 03/2018 - 01/2005
8	Stomach Neoplasms (Stomach Cancer) 01/2020 - 07/2010
6	Carcinogenesis 06/2018 - 01/2005
6	Lymphatic Metastasis 06/2018 - 11/2008
4	Myocardial Infarction 10/2023 - 01/2020
3	Inflammation (Inflammations) 10/2023 - 01/2020
3	Carcinoma (Carcinomatosis) 06/2018 - 02/2011
2	Neoplasm Metastasis (Metastasis) 11/2023 - 03/2018
2	Fibrosis (Cirrhosis) 10/2023 - 01/2022
2	Osteoarthritis 10/2023 - 01/2019
2	Wounds and Injuries (Trauma) 01/2020 - 01/2019
2	Hypersensitivity (Allergy) 01/2018 - 12/2014
2	Triple Negative Breast Neoplasms 10/2016 - 06/2014
1	Infections 11/2023
1	Hypoxia (Hypoxemia) 10/2023
1	Digestive System Diseases 02/2023
1	Rheumatoid Arthritis 02/2023
1	Necrosis 02/2023
1	Disease Resistance 01/2023
1	Surgical Wound 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Ventricular Remodeling 01/2022
1	Atherosclerosis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Non-alcoholic Fatty Liver Disease 08/2018
1	Lung Neoplasms (Lung Cancer) 07/2016
1	Hepatocellular Carcinoma (Hepatoma) 10/2015
1	Asthma (Bronchial Asthma) 11/2011
1	Respiratory Hypersensitivity 11/2011

Drug/Important Bio-Agent (IBA)

11	Estrogens (Estrogen)FDA Link 01/2020 - 11/2005
8	Estrogen ReceptorsIBA 01/2020 - 11/2005
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2009
6	Estrogen Receptor alphaIBA 07/2010 - 01/2005
5	Tamoxifen FDA LinkGeneric 03/2018 - 07/2009
3	CytokinesIBA 11/2023 - 12/2006
3	Caveolin 1IBA 02/2011 - 01/2005
3	human estrogen receptor alpha 36IBA 07/2010 - 11/2008
2	HydrogelsIBA 10/2023 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 01/2020
2	LipidsIBA 01/2022 - 08/2018
2	Biocompatible Materials (Biomaterials)IBA 01/2020 - 01/2019
2	Endoplasmic Reticulum Chaperone BiPIBA 06/2018 - 12/2017
2	Formaldehyde (Formol)FDA Link 12/2014 - 01/2011
2	ParaffinIBA 12/2014 - 01/2011
2	Cyclin D1IBA 12/2014 - 08/2013
2	Transcription Factors (Transcription Factor)IBA 02/2011 - 04/2009
2	Messenger RNA (mRNA)IBA 07/2010 - 11/2008
1	Phytoestrogens (Phytoestrogen)IBA 11/2023
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 11/2023
1	Huang QiIBA 11/2023
1	Interleukin-6 (Interleukin 6)IBA 11/2023
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 11/2023
1	jasmonic acid (jasmonate)IBA 11/2023
1	ethyleneIBA 11/2023
1	AcidsIBA 10/2023
1	CollagenIBA 10/2023
1	EstersIBA 10/2023
1	Infliximab (Remicade)FDA Link 10/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023
1	EnzymesIBA 02/2023
1	LigandsIBA 02/2023
1	BerberineIBA 02/2023
1	Matrix Metalloproteinases (MMPs)IBA 02/2023
1	Therapeutic UsesIBA 02/2023
1	pneumococcal purpura-producing principle (PPPP)IBA 01/2023
1	Elastomers (Elastomer)IBA 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	Polyglactin 910IBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 06/2018
1	Hormones (Hormone)IBA 03/2018
1	Aldehyde DehydrogenaseIBA 03/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	forsythiasideIBA 01/2018
1	AntioxidantsIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Anthocyanins (Anthocyanin)IBA 10/2016
1	SNG1153IBA 07/2016
1	Antineoplastic Agents (Antineoplastics)IBA 07/2016
1	icaritinIBA 10/2015
1	Epithelial Cell Adhesion MoleculeIBA 10/2015
1	human ERBB2 proteinIBA 06/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2014
1	anthrapyrazoleIBA 01/2014
1	PolyaminesIBA 01/2014
1	pterostilbeneIBA 01/2014
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2014
1	CaspasesIBA 01/2014
1	glucose-regulated proteinsIBA 09/2013
1	AllergensIBA 11/2011
1	MicroRNAs (MicroRNA)IBA 01/2011

Therapy/Procedure

6	Therapeutics 11/2023 - 06/2006
3	Drug Therapy (Chemotherapy) 09/2021 - 07/2009
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2023
1	Sternotomy 01/2023
1	Radiotherapy 09/2021
1	Neoadjuvant Therapy 06/2014